Sort
82,697 grants matching “vaccine development”
Bacteria and Host in TB Transmission
$1,612,367David Alland · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT
$1,612,342Medical Research Council Of South Africa · U01 · FY2001 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,612,019Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,611,898John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
DEVELOPMENT OF A NEW, MORE EFFECTIVE LIVE-ATTENUATED INFLUENZA VACCINE: AN ESSENTIAL PLATFORM FOR FUTURE PANDEMIC PROTECTION
$1,611,885University Of Rochester · · FY2017 · Department of the Army
Toxic substances in the environment
$1,611,169Martyn T Smith · University Of California Berkeley · P42 · FY2023 · ES
DNA/MWA Immunogens, Cross-clade Immune Responses
$1,610,907Emory University · P01 · FY2001 · AI
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
$1,610,715Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · IP
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
$1,610,715Vel Murugan · Arizona State University-Tempe Campus · U01 · FY2025 · IP
Novel inhibitors of the replication of poxviruses
$1,610,556Katholieke Universiteit Leuven · UC1 · FY2004 · AI
Pre-Clinical Immunogenicity Testing of Chimp Adenovirus Vectors
$1,610,354Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI
Monoclonal Antibodies in Biodefense: Ebola Viruses
$1,610,165Larry Zeitlin · Mapp Biopharmaceutical, Inc. · U01 · FY2009 · AI
University of Washington Arboviral Research Network (UWARN)
$1,609,959Wesley C Van Voorhis · University Of Washington · U01 · FY2023 · AI
Seattle-Lausanne Clinical Trials Unit
$1,608,983Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
AIDS CLINICAL TRIALS UNIT
$1,608,484Stanford University · U01 · FY2004 · AI
Immune Function and Biodefense in Immunocrompromised Populations
$1,608,352Kathleen Sullivan · Children'S Hosp Of Philadelphia · N01 · FY2010 · AI
Non-Human Primate Core
$1,607,891Kathryn Foulds · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Non-Human Primate Core
$1,607,891Kathryn Foulds · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Emory/Atlanta Center for AIDS Research
$1,607,431James W. Curran · Emory University · P30 · FY2007 · AI
Cellular and Molecular Physiology of Bloodstream Malaria Parasites
$1,606,900Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Combining germline-targeting, B cell immunofocusing and Env-Ab coevolution strategies to induce HIV Envelope V2-apex broadly neutralizing antibodies
$1,606,895Raiees Ahmad Andrabi · University Of Pennsylvania · R33 · FY2025 · AI
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,606,853Michael B Oldstone · Scripps Research Institute, The · U01 · FY2007 · AI
Molecular Genetics Of Scrapie Pathogenesis
$1,606,708Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Evolution & Maintenance of Memory CD8 T Cells
$1,605,917Katherine F Luzuriaga · Univ Of Massachusetts Med Sch Worcester · P01 · FY2007 · AI
PPG: SARS-CoV-host cell interactions and vaccine development
$1,605,748Stanley Perlman · University Of Iowa · P01 · FY2013 · AI